SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 273 filers reported holding SAGE THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $56,000 | -27.3% | 771 | +40.2% | 0.00% | -100.0% |
| Q3 2019 | $77,000 | -78.1% | 550 | -71.4% | 0.00% | -66.7% |
| Q2 2019 | $351,000 | +457.1% | 1,922 | +380.5% | 0.00% | – |
| Q1 2019 | $63,000 | +96.9% | 400 | +19.8% | 0.00% | – |
| Q4 2018 | $32,000 | -60.5% | 334 | -41.2% | 0.00% | -100.0% |
| Q3 2018 | $81,000 | +11.0% | 568 | +24.0% | 0.00% | 0.0% |
| Q2 2018 | $73,000 | 0.0% | 458 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $73,000 | +15.9% | 458 | +19.9% | 0.00% | 0.0% |
| Q4 2017 | $63,000 | +6200.0% | 382 | +2022.2% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 18 | +63.6% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | 0.0% | 11 | 0.0% | 0.00% | – |
| Q3 2016 | $1,000 | – | 11 | -31.2% | 0.00% | – |
| Q2 2016 | $0 | -100.0% | 16 | 0.0% | 0.00% | – |
| Q1 2016 | $1,000 | -50.0% | 16 | -52.9% | 0.00% | – |
| Q4 2015 | $2,000 | +100.0% | 34 | +78.9% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 19 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | – | 19 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sio Capital Management, LLC | 179,200 | $29,516,000 | 16.65% |
| TRV GP II, LLC | 547,916 | $90,247,000 | 16.25% |
| Opus Point Partners Management, LLC | 71,000 | $11,694,000 | 10.12% |
| Casdin Capital, LLC | 250,000 | $41,178,000 | 10.03% |
| RA Capital Management | 455,173 | $74,972,000 | 6.27% |
| Crawford Lake Capital Management, LLC | 154,278 | $25,411,000 | 6.00% |
| Palo Alto Investors LP | 810,806 | $133,548,000 | 5.75% |
| GREAT POINT PARTNERS LLC | 200,000 | $32,942,000 | 5.62% |
| BB BIOTECH AG | 1,042,439 | $171,700,000 | 4.84% |
| Crawford Lake Capital Management, LLC | 92,300 | $15,203,000 | 3.59% |